Institutional investors purchased a net $48.7 thousand shares of MNOV during the quarter ended June 2013. This may signal that the smart money is gaining interest in this company as the 3.96% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BRIDGEWAY CAPITAL MANAGEMENT, IN... Bought 40.0 Thousand shares of MediciNova Inc
FIRST NEW YORK SECURITIES LLC Bought 29.0 Thousand shares of MediciNova Inc
GEODE CAPITAL MANAGEMENT LLC Bought 5.5 Thousand shares of MediciNova Inc